Early Academic Pursuits
Dr. Elgharably began his medical education at Zagazig University in Egypt, where he completed his M.B.Ch.B. degree in 2006. His academic journey continued with a Master’s in Surgery from the same institution, followed by post-doctoral research at Ohio State University and Cleveland Clinic. In 2019, he commenced his PhD at Case Western Reserve University, focusing on modulating microRNA expression in human lungs to attenuate ischemia-reperfusion injury. This diverse background allowed him to bridge clinical practice with cutting-edge research, laying the foundation for his future academic success.
Professional Endeavors
Dr. Elgharably’s career has been marked by significant clinical and professional appointments. At Cleveland Clinic’s Heart & Vascular Institute, he currently serves as a surgical director at the Endocarditis Center and holds the title of co-quality director. His work focuses on high-risk cardiac surgeries, particularly complex procedures for endocarditis and heart valve diseases. He is renowned for his expertise in mitral and tricuspid valve surgeries, lung transplantation, and ischemic heart disease. As a staff member, he mentors young professionals, contributing to the high standard of care at the Cleveland Clinic.
Research Focus and Impact
Dr. Elgharably’s research revolves around ischemia-reperfusion injury, microRNA expression, and infectious endocarditis. His PhD research explores how altering microRNA expression can reduce the harmful effects of ischemia-reperfusion injury in lung transplantation, a novel avenue with significant potential to improve outcomes in lung transplants. His work on biofilm in infective endocarditis and the development of preclinical models has contributed to advancing understanding of infection and wound healing post-surgery. He has presented his research at national and international forums, including the International Society of Heart & Lung Transplantation.
Academic Citations and Recognition
Dr. Elgharably has been recognized by peers for his scholarly contributions, including awards like the Cardiac Teacher of the Year (2021-2022) at Cleveland Clinic. He is a member of the editorial board of Current Challenges in Thoracic Surgery, where his expertise and research contribute to advancing the field. His citations and influence in the cardiothoracic surgery community highlight his role in shaping the future of surgical and therapeutic practices.
Technical Skills
Dr. Elgharably is highly skilled in advanced cardiac surgery, with specialized expertise in mitral and tricuspid valve repair, complex aortic surgeries, and the surgical management of endocarditis. He is also proficient in transplant surgery, particularly in the field of lung transplantation and ECMO (extracorporeal membrane oxygenation) support. His technical prowess is complemented by his ability to perform cutting-edge research and apply findings to clinical practice, improving patient outcomes and surgical techniques.
Teaching Experience and Legacy
Dr. Elgharably is deeply committed to educating the next generation of surgeons. He has been invited to deliver lectures at national and international conferences, such as those hosted by the American Association for Thoracic Surgery and the Society of Thoracic Surgery. He also teaches locally at Cleveland Clinic, providing residents and fellows with invaluable insights into advanced cardiac surgery, lung transplantation, and the complexities of endocarditis. He sponsors and presents at the Research Day of the Thoracic & Cardiovascular Surgery Department, offering an avenue for emerging scholars to showcase their work. His legacy will be marked by his mentorship and the many surgeons he has trained.
🌍 Future Contributions and Impact
Dr. Elgharably is positioned for continued success, with an ongoing commitment to improving patient outcomes, advancing medical research, and developing innovative surgical techniques. His PhD research, focused on microRNA modulation and ischemia-reperfusion injury, holds promise for revolutionizing transplant surgery, while his leadership roles at Cleveland Clinic will allow him to influence the future of cardiac surgery and thoracic interventions. As he continues to train young surgeons and contribute to cutting-edge research, Dr. Elgharably’s impact on the field will only grow.
Publications